Correlation Between Kinetics Spin-off and Balter Invenomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kinetics Spin-off and Balter Invenomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinetics Spin-off and Balter Invenomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kinetics Spin Off And and Balter Invenomic Fund, you can compare the effects of market volatilities on Kinetics Spin-off and Balter Invenomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinetics Spin-off with a short position of Balter Invenomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinetics Spin-off and Balter Invenomic.

Diversification Opportunities for Kinetics Spin-off and Balter Invenomic

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kinetics and Balter is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Kinetics Spin Off And and Balter Invenomic Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Balter Invenomic and Kinetics Spin-off is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinetics Spin Off And are associated (or correlated) with Balter Invenomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Balter Invenomic has no effect on the direction of Kinetics Spin-off i.e., Kinetics Spin-off and Balter Invenomic go up and down completely randomly.

Pair Corralation between Kinetics Spin-off and Balter Invenomic

Assuming the 90 days horizon Kinetics Spin Off And is expected to generate 2.92 times more return on investment than Balter Invenomic. However, Kinetics Spin-off is 2.92 times more volatile than Balter Invenomic Fund. It trades about 0.04 of its potential returns per unit of risk. Balter Invenomic Fund is currently generating about 0.05 per unit of risk. If you would invest  3,742  in Kinetics Spin Off And on November 28, 2024 and sell it today you would earn a total of  52.00  from holding Kinetics Spin Off And or generate 1.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kinetics Spin Off And  vs.  Balter Invenomic Fund

 Performance 
       Timeline  
Kinetics Spin Off 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kinetics Spin Off And has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's technical and fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Balter Invenomic 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Balter Invenomic Fund are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Balter Invenomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Kinetics Spin-off and Balter Invenomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kinetics Spin-off and Balter Invenomic

The main advantage of trading using opposite Kinetics Spin-off and Balter Invenomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinetics Spin-off position performs unexpectedly, Balter Invenomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balter Invenomic will offset losses from the drop in Balter Invenomic's long position.
The idea behind Kinetics Spin Off And and Balter Invenomic Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance